"Insulin Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which inhibit or antagonize the biosynthesis or action of insulin.
| Descriptor ID |
D007329
|
| MeSH Number(s) |
D06.347.420 D27.505.696.399.450.420
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Insulin Antagonists".
This graph shows the total number of publications written about "Insulin Antagonists" by people in this website by year, and whether "Insulin Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Antagonists" by people in Profiles.
-
Substoichiometric Inhibition of Insulin against IAPP Aggregation Is Attenuated by the Incompletely Processed N-Terminus of proIAPP. ACS Chem Neurosci. 2022 07 06; 13(13):2006-2016.
-
PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet. 2002 Jul 15; 11(15):1687-96.